Pharmacogenomics

 CYP2C9
CYP2C9 is responsible for the oxidative metabolism of several drugs, including some antagonist of the angiotensin II receptor, NSAIs, warfarin, fluoxetine, and some tricyclic antidepressants. The gene encoding this enzyme may present the normal allele (CYP2C9 * 1), or two polymorphisms (CYP2C9 * 2 and CYP2C9 * 3), which cause a reduction in the enzyme's activity.

Our kit detects both polymorphisms, helping to identify those patients that may require dose adjustment or drug substitution.